Ethos Technologies Inc. (LIFE) Q4 2024 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Ethos Technologies Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:05.357 Good afternoon, ladies and gentlemen, and welcome to the Atire Pharma fourth quarter 00:00:05.357 -- 00:00:10.503 and full year 2024 conference call. At this time, all participants 00:00:10.503 -- 00:00:16.109 are in a listen only mode. Later, we will conduct a question and answer session 00:00:16.109 -- 00:00:18.611 and instructions will be given at that time. 00:00:18.611 -- 00:00:24.618 As a reminder, this conference is being recorded for replay purposes. 00:00:24.618 -- 00:00:29.647 It is now my pleasure to hand the conference call over to Ashley Dunston, 00:00:29.647 -- 00:00:35.034 a TIRES Senior Director of Investor Relations and Public Affairs. 00:00:35.034 -- 00:00:37.236 Ms. Dunstan, you may begin. 00:00:37.236 -- 00:00:38.878 Thank 00:00:38.878 -- 00:00:43.904 you and good afternoon, everyone. Thank you for joining us today to discuss a TIRES 00:00:43.904 -- 00:00:48.490 fourth quarter and full year 2024 operating results and corporate update. 00:00:48.490 -- 00:00:52.475 We are joined today by Dr. Sanjay Shukla, our President and CEO, Ms. 00:00:52.475 -- 00:00:57.271 Jill Broadfoot, our CFO, and Dr. Leslie Nangle, Vice President of Research. 00:00:57.271 -- 00:01:01.577 On the call, Sanjay will provide an update on our corporate strategy, including our clinical 00:01:01.577 -- 00:01:06.142 program for efsofitamide. Leslie will discuss our research and discovery programs while 00:01:06.142 -- 00:01:10.348 Jill will review the financial results and our current financial position before handing 00:01:10.348 -- 00:01:13.632 it back to Sanjay to open up the call for any questions. 00:01:13.632 -- 00:01:18.258 Before we begin, I want to remind everyone that except for statements of historical facts, 00:01:18.258 -- 00:01:22.2...